Evidence map›Paper›PMID 27610192›Full record

ArticleInfectious agents and cancer2016

Molecular analysis of human Papillomavirus detected among women positive for cervical lesions by visual inspection with acetic acid/Lugol's iodine (VIA/VILI) in Libreville, Gabon.

Pamela Boundzanga Moussavou, Ismaël Hervé Koumakpayi, Andriniaina Andy Nkili-Meyong, Ingrid Labouba, Ulrich Bisvigou, Junie K Chansi, Corinne Engohan-Aloghe, Frederic Dissanami, Nathalie Ambounda, Anne-Sophie Delannoy-Vieillard and 5 more

Open access · goldAbstract read
In one paragraph

Article in Infectious agents and cancer, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 2 countries.

Pamela Boundzanga MoussavouDepartment of Zoonosis and Emerging Diseases, Centre International de Recherches Médicales de Franceville (CIRMF), Franceville, BP 769 Gabon.
Ismaël Hervé KoumakpayiInstitut de Cancérologie de Libreville (ICL), Libreville, Gabon.
Andriniaina Andy Nkili-MeyongDepartment of Zoonosis and Emerging Diseases, Centre International de Recherches Médicales de Franceville (CIRMF), Franceville, BP 769 Gabon.
Ingrid LaboubaDepartment of Zoonosis and Emerging Diseases, Centre International de Recherches Médicales de Franceville (CIRMF), Franceville, BP 769 Gabon.
Ulrich BisvigouInstitut de Cancérologie de Libreville (ICL), Libreville, Gabon.
Junie K ChansiInstitut de Cancérologie de Libreville (ICL), Libreville, Gabon.
Corinne Engohan-AlogheInstitut de Cancérologie de Libreville (ICL), Libreville, Gabon.
Frederic DissanamiCentre Hospitalier Universitaire de Libreville (CHUL), Service de gynécologie obstétrique, Libreville, Gabon.
Nathalie AmboundaCentre Hospitalier Universitaire de Libreville (CHUL), Service de gynécologie obstétrique, Libreville, Gabon.
Anne-Sophie Delannoy-VieillardInstitut Pasteur, Unité Environnement et risques infectieux, Cellule d'Intervention Biologique d'Urgence, Paris, France.
Laure DiancourtInstitut Pasteur, Unité Environnement et risques infectieux, Cellule d'Intervention Biologique d'Urgence, Paris, France.
Dieudonne NkogheDepartment of Zoonosis and Emerging Diseases, Centre International de Recherches Médicales de Franceville (CIRMF), Franceville, BP 769 Gabon ; Ministère de la Santé, Direction général de la Santé, Libreville, Gabon.
Eric M LeroyDepartment of Zoonosis and Emerging Diseases, Centre International de Recherches Médicales de Franceville (CIRMF), Franceville, BP 769 Gabon ; Institut de Recherches et de Développement (IRD), Maladies Infectieuses et vecteurs: Ecologie, génétique, Evolution et Contrôle (IRD 224 - CNRS 5290 6 UM1- UM2), Montpellier, France.
Ernest BelembaogoInstitut de Cancérologie de Libreville (ICL), Libreville, Gabon.
Nicolas BerthetDepartment of Zoonosis and Emerging Diseases, Centre International de Recherches Médicales de Franceville (CIRMF), Franceville, BP 769 Gabon ; Centre National de la Recherche Scientifique, UMR3569, Paris, France.
Libreville Hospital · GACentre International de Recherches Médicales de Franceville · GAInstitut Pasteur · FRCentre de Gestion Scientifique · FRMaladies Infectieuses et Vecteurs: Écologie, Génétique, Évolution et Contrôle · FRUniversité des Sciences de la Santé · GA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe human papillomavirus (HPV) is the causative agent of cervical cancer, which is the leading cancer-related cause of death for women in Sub-Saharan Africa. In 2013, the Gabonese Ministry of Health and the Sylvia Bongo Ondimba Foundation implemented cervical cancer screening programs based on the detection of cancerous lesions by visual inspection with acetic acid and/or Lugol's iodine (VIA/VILI). This pilot study was set up to determine the HPV profile and analyze the nucleotide sequence variation of HPV16 circulating in patients with cervical abnormalities detected by VIA/VILI testing.

methodsThe cervical abnormalities observed upon VIA/VILI were confirmed by liquid-based cytology for all tested women. Nested PCR using the MY09/11 and GP5+/6+ primer sets was used to detect HPVs present in the extracted DNA. HPV genotypes were determined after sequencing of amplicons based on a high-throughput sequencing approach. For isolates of the HPV16 genotype, the E6 gene and the long control region (LCR) were directly sequenced using Sanger method.

resultsThe study included 87 women who showed a positive VIA/VILI result. Cervical abnormalities were found in 40.23 % of women and 40 % were classified as high-grade lesions. The HPV detection rate was 82.9 % among women with abnormal cytology. Among all the identified high-risk HPV genotypes, HPV16, 18 and 33 were the most frequent. Multiple HPV infections were observed in 42.31 % of HPV-infected women. Analysis of the HPV16 sequence variation in the E6 gene and in the LCR showed that 85.3 and 14.7 % belonged to the African and European lineages, respectively. Among the African branch variants, Af2 was the most frequently identified in this study.

conclusionThis study offers the first report of the HPV detection rate and molecular epidemiology among Gabonese women with a positive result in a VIA/VILI screening test. Moreover, data on the HPV16 sequence variation confirm the predominance of African variants in high-grade lesions.

Indexed as

Detection rateGabonHuman papillomavirusMolecular variantVisual inspection

Identifiers

PMID27610192
PMCPMC5015258
OpenAlexW2509874495

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.